Literature DB >> 22468057

Study of immunohistochemistry in prostatic lesions with special reference to proliferation and invasiveness.

Asim Kumar Manna, Swapan Pathak, Prosenjit Gayen, Diptendra Kumar Sarkar, Anup Kumar Kundu.   

Abstract

Prostatic lesions on routine staining sometimes cause diagnostic dilemma especially in premalignant lesions like atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia. Benign small acinar lesions also may be difficult to differentiate from small acinar adenocarcinoma. An important differentiating point is the loss of basal cell layer in adenocarcinoma and its presence in benign lesions. Basal cell markers (e.g. 34βE12 cytokeratin) & proliferative markers (e.g. AgNOR and PCNA) can help in this regard. Total 60 cases of different prostatic lesions studied. After history taking, clinical examination, radiological & other investigations were done. Routine H&E staining, immunohistochemical staining against 34βE12 cytokeratin & proliferative markers (AgNOR & PCNA) was performed. Statistically significant differences found in expression of 34βE12 cytokeratin and proliferative markers between benign, premalignant and malignant prostatic lesions. Basal cell markers and proliferative markers are important parameters to distinguish between different benign, premalignant and malignant prostatic lesions.

Entities:  

Keywords:  34βE12; AgNOR; Immunohistochemistry; PCNA; Prostate

Year:  2010        PMID: 22468057      PMCID: PMC3077171          DOI: 10.1007/s12262-010-0180-7

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  16 in total

1.  Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.

Authors:  Rajal B Shah; Ming Zhou; Michele LeBlanc; Matthew Snyder; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

2.  Microscopic differential diagnosis of latent carcinoma of prostate.

Authors:  R S TOTTEN; M W HEINEMANN; P B HUDSON; E E SPROUL; A P STOUT
Journal:  AMA Arch Pathol       Date:  1953-02

3.  Role of proliferative markers in prostatic lesions.

Authors:  Joybandhu Ghosh; Ashok Burman; Asim Kumar Manna; Amitabha Chatterjee
Journal:  Indian J Pathol Microbiol       Date:  2004-07       Impact factor: 0.740

4.  Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland.

Authors:  F P O'Malley; D J Grignon; D T Shum
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma.

Authors:  L Hedrick; J I Epstein
Journal:  Am J Surg Pathol       Date:  1989-05       Impact factor: 6.394

6.  Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.

Authors:  Ming Zhou; Rajal Shah; Ronglai Shen; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

7.  Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer.

Authors:  X J Yang; K Lecksell; P Gaudin; J I Epstein
Journal:  Am J Surg Pathol       Date:  1999-02       Impact factor: 6.394

8.  Variations in the occurrence of silver-staining nucleolar organizer regions (AgNORs) in non-proliferating and proliferating tissues.

Authors:  R D Leek; M R Alison; C E Sarraf
Journal:  J Pathol       Date:  1991-09       Impact factor: 7.996

9.  Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.

Authors:  B Helpap
Journal:  Pathol Res Pract       Date:  1995-09       Impact factor: 3.250

10.  Nucleolar organizer regions and PCNA expression in prostatic cancers.

Authors:  N Kawase; A Shiokawa; H Ota; T Saitoh; H Yoshida; K Kazama
Journal:  Pathol Int       Date:  1994-03       Impact factor: 2.534

View more
  4 in total

1.  Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion.

Authors:  Juan Li; Jie Liu; Pingping Li; Xiaona Mao; Wenjie Li; Jin Yang; Peijun Liu
Journal:  J Exp Clin Cancer Res       Date:  2014-09-02

2.  Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.

Authors:  James Olayiwola Adisa; Ejike Chukwudi Egbujo; Babangida Ibrahim; Bukar Musa; Jonathan Madukwe
Journal:  Pan Afr Med J       Date:  2015-01-16

3.  Histopathological spectrum of 364 prostatic specimens including immunohistochemistry with special reference to grey zone lesions.

Authors:  Monika Garg; Gurmeen Kaur; Vineeta Malhotra; Ravish Garg
Journal:  Prostate Int       Date:  2013-12-30

4.  Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions.

Authors:  Eiman Siddig Ahmed; Lubna S Elnour; Rowa Hassan; Emmanuel E Siddig; Mintu Elsa Chacko; Eman T Ali; Mona A Mohamed; Abdalla Munir; Mohamed S Muneer; Nouh S Mohamed; Ali M M Edris
Journal:  BMC Res Notes       Date:  2020-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.